Near a 12-year low, Kimberly-Clark may be one of the best deep value stocks for income investors to buy in 2026.

Kimberly-Clark is buying Tylenol maker Kenvue in a cash and stock deal worth about $48.7 billion, creating a massive consumer health goods company. Shareholders of Kimberly-Clark will own about 54% of ...

Staff report Kimberly-Clark Corp. and Kenvue Inc. announced that the shareholders of both boards voted Thursday to approve ...

Kimberly-Clark is buying Tylenol maker Kenvue in a cash and stock deal worth about $48.7 billion, creating a huge consumer health goods company. Shareholders of Kimberly-Clark will own about 54% of ...

Kimberly-Clark Corporation (NASDAQ: KMB) and Kenvue Inc. (NYSE: KVUE) today announced that Kimberly-Clark and Kenvue shareholders voted overwhelmingly to approve all of the proposals necessary for ...

The merger of two household-name companies will protect jobs in Chester, Fort Washington, and Lititz while strengthening U.S. competitiveness against China in the consumer health market.

Monday - Friday, 6:00 - 7:00 PM ET Kimberly-Clark CEO Mike Hsu told CNBC's Jim Cramer that his company's acquisition of Tylenol maker Kenvue will create value for shareholders, even as the pain ...

Kimberly-Clark Corporation (NASDAQ:KMB) is one of the stocks Jim Cramer recently put under a microscope. Cramer discussed the company’s planned acquisition, as he commented: “Sometimes when stocks are ...

Household products company Kimberly-Clark (NYSE:KMB) in Q4 CY2025, but sales were flat year on year at $4.08 billion. Its non-GAAP profit of $1.86 per share was 2.7% above analysts’ consensus ...